Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 7;10(11):2834.
doi: 10.3390/biomedicines10112834.

Emerging Role of YAP and the Hippo Pathway in Prostate Cancer

Affiliations
Review

Emerging Role of YAP and the Hippo Pathway in Prostate Cancer

Filippos Koinis et al. Biomedicines. .

Abstract

The Hippo pathway regulates and contributes to several hallmarks of prostate cancer (PCa). Although the elucidation of YAP function in PCa is in its infancy, emerging studies have shed light on the role of aberrant Hippo pathway signaling in PCa development and progression. YAP overexpression and nuclear localization has been linked to poor prognosis and resistance to treatment, highlighting a therapeutic potential that may suggest innovative strategies to treat cancer. This review aimed to summarize available data on the biological function of the dysregulated Hippo pathway in PCa and identify knowledge gaps that need to be addressed for optimizing the development of YAP-targeted treatment strategies in patients likely to benefit.

Keywords: Hippo pathway; YAP; YAP/TAZ signaling; prostate cancer; prostate cancer hallmarks.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Hippo YAP/TAZ signaling pathway in early PCa. When the Hippo pathway is switched ON, phosphorylation of Mst1 and Lats1 by Merlin and MAPK leads to phosphorylation of YAP/TAZ that forms a complex with 14–3–3 protein in the cytoplasm. VGLL4 binds to TEAD binding promoters thus, blocking the expression of genes important for proliferation, migration and tumorigenesis. In the OFF condition, in early prostate tumor cells, Lats1/2 is dephosphorylated due to various mechanisms such as degradation of Mst1/2 by Hsp27, complex formation of Lats1/2 with Par3 and Merlin and dissociation of Lats1/2 and KIBRA complex by Par3. Due to blocking of physiological kinase cascade of the Hippo pathway, unphosphorylated YAP/TAZ enters the nucleus and act as co-regulator of TEAD transcription factors leading to expression of target genes.
Figure 2
Figure 2
YAP and the Hallmarks of Cancer.

Similar articles

Cited by

References

    1. Siegel R.L., Miller K.D., Jemal A. Cancer Statistics, 2019. CA Cancer J. Clin. 2019;69:7–34. doi: 10.3322/caac.21551. - DOI - PubMed
    1. American Cancer Society Cancer Facts and Figures 2017. Genes Dev. 2017;21:2525–2538.
    1. Higa J., Wilenius K., Weidhaas J.B., Larsen C., Lam R.Y., Turner J., Scholz M.C. Pembrolizumab for Recurrent or Advanced Prostate Cancer. J. Clin. Oncol. 2018;36:250. doi: 10.1200/JCO.2018.36.6_suppl.250. - DOI
    1. Abida W., Bryce A.H., Vogelzang N.J., Amato R.J., Percent I., Shapiro J.D., McDermott R., Hussain A., Patnaik A., Petrylak D., et al. Preliminary Results from TRITON2: A Phase II Study of Rucaparib in Patients (Pts) with Metastatic Castration-Resistant Prostate Cancer (MCRPC) Associated with Homologous Recombination Repair (HRR) Gene Alterations. Ann. Oncol. 2018;29:viii272. doi: 10.1093/annonc/mdy284.002. - DOI
    1. Mateo J., Carreira S., Sandhu S., Miranda S., Mossop H., Perez-Lopez R., Nava Rodrigues D., Robinson D., Omlin A., Tunariu N., et al. DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer. N. Engl. J. Med. 2015;373:1697–1708. doi: 10.1056/NEJMoa1506859. - DOI - PMC - PubMed

Grants and funding

This research received no external funding.

LinkOut - more resources